Financials
Value Q2, 25Q3, 25 TTM Selling/general/admin expenses —60 K — Research & development —— — Operating income -77.89 K-191.05 K — Non-Operating Income, Total —1.16 M — Interest expense, net of interest capitalized —— — Non-Operating Income, excl. Interest Expenses —1.16 M — Unusual income/expense —— — Pretax income -77.89 K971.95 K — Equity in earnings —— — Taxes —— — Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations -77.89 K971.95 K — Discontinued operations —— — Net income -77.89 K971.95 K — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders -77.89 K971.95 K — Basic earnings per share (Basic EPS) -0.020.06 — Diluted earnings per share (Diluted EPS) -0.020.06 — Average basic shares outstanding 3.33 M11.12 M — Diluted shares outstanding 3.33 M11.12 M — EBITDA —— — EBIT —— — Cost of revenue —— — Other cost of goods sold —— — Depreciation & amortization (cash flow) —— —